Coral Genomics Company

Coral develops new clinical tests to help providers streamline prior authorization and select the effective medication for a particular patient focusing on autoimmune conditions such as Inflammatory Bowel Disease and Rheumatoid Arthritis. It has also identified a unique population of non-responder patients and is working with drug developers to address this unmet medical need.
Technology: Biotechnology, Genetics, Health Care
Industry: Clinical Development, Data Processing
Headquarters: San Francisco, California, United States
Founded Date: 2018-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 7
Total Funding: 5700000
Estimated Revenue: Less than $1M
Last Funding Date: 2021-01-28
Last Funding Type: Grant

Visit Website
Register and Claim Ownership